Mucomyst and Adalat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mucomyst (acetylcysteine) and Adalat (nifedipine). Common drug interactions include multi-organ failure among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Mucomyst and Adalat. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Mucomyst?

Mucomyst has active ingredients of acetylcysteine. eHealthMe is studying from 1,835 Mucomyst users. Check the latest studies of Mucomyst.

What is Adalat?

Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.

On Jul, 28, 2026

15 people who take Mucomyst and Adalat together, and have interactions are studied.

What are the common drug interactions of Mucomyst and Adalat, by gender? *:

female:

Multi-organ failure (multisystem organ failure)
Pain
Percutaneous coronary intervention
Pleural effusion (water on the lungs)
Proteinuria (presence of protein in the urine)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Stress
White blood cell count increased

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Electrocardiogram qt prolonged
Hepatic steatosis (fatty liver disease)
Hepatitis (inflammation of the liver)
Hepatocellular damage (liver damage)
Hepatomegaly (abnormal enlargement of the liver)
Hyperkalaemia (damage to or disease of the kidney)
Hyperlipidaemia (presence of excess lipids in the blood)
Hyperthermia malignant (disease passed down through families that causes a fast rise in body temperature (fever) and severe muscle contractions)

What are the common drug interactions of Mucomyst and Adalat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiomegaly (increased size of heart than normal)
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Diffuse alveolar damage (common manifestation of drug-induced lung injury)
Drug administration error
Electrocardiogram st-t change
Electrocardiogram t wave inversion
General physical health deterioration (weak health status)
Hypotension (abnormally low blood pressure)
Muscle necrosis (muscle cell damage)

40-49:

Abdominal pain upper
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Dyspnoea (difficult or laboured respiration)
Oxygen saturation decreased
Rales (an abnormal respiratory sound characterized by fine crackles)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Drug exposure during pregnancy
Proteinuria (presence of protein in the urine)

50-59:

Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Arteriosclerosis (thickening and hardening of arteries)
Bradycardia (abnormally slow heart action)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Cardiac failure congestive
Chest pain
Dyspnoea (difficult or laboured respiration)
Hyperkalaemia (damage to or disease of the kidney)
Hypotension (abnormally low blood pressure)

60+:

Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Iodine uptake increased
Anxiety
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Asthenia (weakness)
Atelectasis (partial or complete collapse of the lung)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Atrioventricular block first degree (heart block first degree)
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 53.33%
Sedation: 4 people, 26.67%
Renal Impairment (severely reduced kidney function): 3 people, 20.00%
Lung Cancer - Non-Small Cell (lung cancer): 3 people, 20.00%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 20.00%
Hepatotoxicity (chemical-driven liver damage): 3 people, 20.00%
Enlarged Prostate: 3 people, 20.00%
Anaemia (lack of blood): 3 people, 20.00%
Uterine Contractions During Pregnancy: 2 people, 13.33%
Stable Angina (a constant chest pain): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Mucomyst and Adalat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously